Tris Pharma has set its sights on an FDA filing for pipeline drug cebranopadol before the end of this year after the drug achieved significant pain relief in abdominoplasty patients in a late-stage ...

Pfizer and manufacturer Tris Pharma have agreed to hand over $41.5 million to lay to rest a 2023 lawsuit accusing the companies of knowingly providing compromised ...

NEW YORK, United States (AFP)—Texas’s top prosecutor on Wednesday announced the state had reached a $41.5 million settlement with US drugmakers Pfizer and Tris Pharma, over allegations of drug ...

FINIX performed their song “Sumugal sa Akin” at the press meet. — BRONTË H. LACSAMANA FOLLOWING the release of their pre-debut EP Thirsty in June, P-pop girl group FINIX (pronounced “phoenix”) has ...

UWF music grad Tris Weeks and her Goldmine Band will release second album on July 24 The University of West Florida grad studied in Ireland last summer at the World Academy of Music The band features ...

Ginny & Georgia is back and (quite possibly) better than ever as season three finally arrived on our Netflix screens late last week. Amongst all the drama (read: Georgia on trial for murder), there's ...

Forbes contributors publish independent expert analyses and insights. Michael Taylor is an Italian-based automotive industry reporter. Fiat Professional has trodden on Italian automotive iconography ...

Fiat Professional reveals Tris three-wheeled EV trucklet, powered by a 6.9-kWh battery. The small commercial EV is Fiat's entry into the sphere of micromobility, with the automaker planning to offer ...

Meet the Tris, a new compact three-wheeler from Fiat that measures 10.4 feet long and has a maximum driving range of 56 miles on the WMTC test. It's effectively an electric rickshaw or tuk-tuk that ...

That’s where this Fiat Tris steps in. Under the Fiat Professional commercial vehicle brand, the Tris will go on sale in India and Africa, although Fiat CEO Olivier Francois has given hope of a launch ...

Thailand's life insurance sector is expected to expand steadily this year, supported by rising health awareness and growing demand for critical illness coverage, while non-life insurers may see ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ALLEVIATE-2 Phase 3 pivotal clinical ...